Rojas, Ruperta .
HRN: 27-08-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/16/2025
05/22/2025
IVT
2 25g
Q8
CAP HR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes